Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 5Lymphoid 1Genitourinary 1CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 171Lymphoma 93Leukemia 63Burkitt Lymphoma 57Lymphoma, Non-Hodgkin 50Lymphoma, Large B-Cell, Diffuse 44Lymphoma, Mantle-Cell 38Lymphoma, Follicular 30Recurrence 29Hodgkin Disease 29Waldenstrom Macroglobulinemia 27Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 27Leukemia, Lymphocytic, Chronic, B-Cell 26Multiple Myeloma 21Lymphoma, B-Cell, Marginal Zone 17Lymphoma, Extranodal NK-T-Cell 16Leukemia, Biphenotypic, Acute 16Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 13Lymphoma, B-Cell 13Leukemia, Myeloid, Acute 13Lymphoma, Large-Cell, Immunoblastic 11Lymphoma, T-Cell, Peripheral 10Neoplasms 9Lymphoma, Large-Cell, Anaplastic 9Lymphoma, T-Cell, Cutaneous 8Lymphoma, T-Cell 7Intraocular Lymphoma 6Hematologic Neoplasms 6Blast Crisis 6Sezary Syndrome 5

Interventions

Magnetic Resonance Spectroscopy 6Cyclophosphamide 6X-Rays 5Phantoms, Imaging 5Filgrastim 5pembrolizumab 4Specimen Handling 4Radiotherapy 4Nuclear Medicine Department, Hospital 4Gemcitabine 4Biopsy 4tazemetostat 3Surveys and Questionnaires 3Psychiatric Rehabilitation 3Etoposide 3Drug Therapy 3Carboplatin 3Busulfan 3Bevacizumab 3ulixertinib 2tipifarnib 2spartalizumab 2selpercatinib 2palbociclib 2olaparib 2larotrectinib 2ivosidenib 2ganitumab 2ensartinib 2aflibercept 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma × Dexamethasone × Lymphoid × Clear all
NCT01236586 2017-07-02

RO4929097 in Children With Relapsed/Refractory Solid or CNS Tumors, Lymphoma, or T-Cell Leukemia

National Institutes of Health Clinical Center (CC)

Phase 1 Withdrawn
CNSGenitourinaryLymphoidSarcoma

Brain Neoplasms, Lymphoma, Neoplasms, Wilms Tumor, Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡